HCA Healthcare Inc (NYSE:HCA) – Equities research analysts at KeyCorp reduced their FY2017 earnings per share (EPS) estimates for HCA Healthcare in a report issued on Wednesday. KeyCorp analyst J. Gurda now forecasts that the company will post earnings of $6.60 per share for the year, down from their prior forecast of $7.21. KeyCorp currently has a “Overweight” rating and a $90.00 target price on the stock.

HCA has been the subject of a number of other research reports. Robert W. Baird reiterated a “buy” rating on shares of HCA Healthcare in a research report on Thursday, September 28th. Zacks Investment Research lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, July 14th. Piper Jaffray Companies reiterated a “buy” rating and set a $92.00 target price on shares of HCA Healthcare in a research report on Wednesday, October 4th. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 target price on shares of HCA Healthcare in a research report on Friday, October 13th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $91.25.

ILLEGAL ACTIVITY WARNING: This article was reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/23/fy2017-earnings-estimate-for-hca-healthcare-inc-hca-issued-by-keycorp.html.

Shares of HCA Healthcare (NYSE HCA) opened at 81.05 on Monday. HCA Healthcare has a 12-month low of $67.00 and a 12-month high of $91.03. The firm has a 50-day moving average of $77.65 and a 200-day moving average of $81.88. The company has a market cap of $29.28 billion, a P/E ratio of 10.86 and a beta of 0.62.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.80 by ($0.05). The business had revenue of $10.73 billion for the quarter, compared to analysts’ expectations of $10.76 billion. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.66 earnings per share.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. APG Asset Management N.V. raised its stake in HCA Healthcare by 141.4% in the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock valued at $272,467,000 after purchasing an additional 2,005,193 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in HCA Healthcare by 1,500.3% in the third quarter. Assenagon Asset Management S.A. now owns 1,579,382 shares of the company’s stock valued at $125,703,000 after purchasing an additional 1,480,690 shares in the last quarter. Mutual of America Capital Management LLC raised its stake in HCA Healthcare by 2.2% in the third quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock valued at $2,844,000 after purchasing an additional 761 shares in the last quarter. Ardsley Advisory Partners purchased a new stake in HCA Healthcare in the second quarter valued at approximately $436,000. Finally, Paulson & CO. Inc. purchased a new stake in HCA Healthcare in the second quarter valued at approximately $7,848,000. 73.76% of the stock is currently owned by institutional investors and hedge funds.

In related news, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $79.88, for a total value of $171,742.00. Following the sale, the insider now directly owns 12,363 shares of the company’s stock, valued at $987,556.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 6,450 shares of company stock worth $511,163 over the last ninety days. 2.90% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.